IFI27 and breast cancer: However, our findings on the effect of ISG12 on the response of breast cancer cells to E2 and TOT suggest the need to explore further whether ISG12 protein overexpression could impair the cellular response to E2 and TOT which is often observed in tumor recurrence and metastatic breast cancer (60–62).